Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-22 Stuart Iain Chief Scientific Officer Grant or award +29,213 100,778
2021-02-22 Stuart Iain Chief Scientific Officer Grant or award · Stock Options +68,162 68,162
2021-02-22 Saik Andrew Chief Financial Officer Grant or award +29,213 114,213
2021-02-22 Saik Andrew Chief Financial Officer Grant or award · Stock Options +68,162 68,162
2021-02-22 Harsch Mutya Chief Legal Officer and GC Grant or award +29,213 110,638
2021-02-22 Harsch Mutya Chief Legal Officer and GC Grant or award · Stock Options +68,162 68,162
2021-02-22 Domzalski David President and CEO Grant or award +153,750 479,833
2021-02-22 Domzalski David President and CEO Grant or award · Stock Options +358,750 358,750
2021-01-28 PERCEPTIVE ADVISORS LLC 10% owner Purchase +4,219,409 $2.37 $10.0M 27,095,819
2020-12-31 Wiley Matthew T. Chief Commercial Officer Shares withheld for taxes −1,541 $1.58 $2K 357,181
2020-12-31 Stuart Iain Chief Scientific Officer Shares withheld for taxes −2,378 $1.58 $4K 286,262
2020-12-31 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −1,822 $1.58 $3K 325,703
2020-12-31 Domzalski David President and CEO Shares withheld for taxes −9,656 $1.58 $15K 1,304,334
2020-12-03 LEPORE PATRICK G Director Purchase +50,000 $1.71 $85K 50,000
2020-11-30 Wiley Matthew T. Chief Commercial Officer Grant or award +7,838 $1.45 $11K 358,722
2020-11-30 Harsch Mutya Chief Legal Officer and GC Grant or award +10,460 $1.45 $15K 327,525
2020-11-30 Domzalski David President and CEO Grant or award +4,263 $1.45 $6K 1,313,990
2020-09-30 Wiley Matthew T. Chief Commercial Officer Shares withheld for taxes −1,541 $1.66 $3K 350,884
2020-09-30 Stuart Iain Chief Scientific Officer Shares withheld for taxes −2,378 $1.66 $4K 288,640
2020-09-30 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −1,822 $1.66 $3K 317,065

Page 11 of 22 · 425 trades